双酚A降低正常体重成人外周胰岛素敏感性:双盲随机对照试验
该双盲随机对照试验纳入40名久坐健康成人,比较口服双酚A(50 µg/kg体重)与安慰剂5天对外周胰岛素敏感性的影响。结果显示BPA组尿BPA显著升高,体重和空腹血糖无差异,但BPA组外周胰岛素敏感性显著下降而安慰剂组上升,提示BPA可能降低胰岛素敏感性。
要点
- 口服BPA 50 µg/kg体重5天可显著降低正常体重成人外周胰岛素敏感性。
- BPA组与安慰剂组体重和空腹血糖无统计学差异。
- 这是首个人体实验证据提示BPA可能降低胰岛素敏感性。
核心结论
- 口服BPA 5天可降低正常体重成人的外周胰岛素敏感性,为首个人体实验证据提示BPA可能降低胰岛素敏感性。
研究设计与样本
- 双盲随机对照试验,40名久坐但健康成人(22女,18男;21.3 ± 2.1岁;BMI 22.1 ± 2.3 kg/m2;85%非西班牙裔白人)。
- 基线2天能量平衡低BPA饮食后,随机接受5天口服BPA 50 µg/kg体重或安慰剂,所有参与者进食相同能量平衡饮食。
- 外周胰岛素敏感性通过120分钟高胰岛素-正葡萄糖钳夹技术评估(40 mU/m2/min;90 mg/dL)。
主要发现
- 治疗后体重和空腹血糖在两组间无统计学差异(P > .05)。
- BPA组外周胰岛素敏感性下降0.02 ± 0.01 mg/kg/min/uU/mL,而安慰剂组上升0.02 ± 0.01 mg/kg/min/uU/mL(P = .01)。
临床怎么用
- 该研究提示短期口服BPA可降低外周胰岛素敏感性,但尚不能直接推导临床干预阈值。
局限性
- 样本为久坐但健康、以非西班牙裔白人为主的年轻成人,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Bisphenol A (BPA) is a synthetic chemical used in consumer goods that has been linked to type 2 diabetes in observational studies. No human experimental studies have examined whether BPA reduces peripheral insulin sensitivity. PURPOSE: To determine the effects of oral BPA administration on peripheral insulin sensitivity over 5 days. METHODS: Forty sedentary, but otherwise healthy adults (22 F, 18 M; 21.3 ± 2.1 year; 22.1 ± 2.3 kg/m2; 85% non-Hispanic White) completed a 2-day baseline energy-balanced diet low in BPA during which urine, blood, and peripheral insulin sensitivity via 120 minutes euglycemic hyperinsulinemic clamp technique (40 mU/m2/min; 90 mg/dL) were assessed. In a double-blind fashion, participants were randomly assigned to receive 5 days of oral BPA administration at 50 µg/kg body weight (BPA-50) or placebo (PL). All participants were fed the same energy-balanced diet. Outcomes were assessed using a two-way repeated-measures ANOVA adjusted for baseline sex, BMI, physical activity, and ethnicity. RESULTS: After treatment, urine BPA levels were significantly higher in BPA-50 compared to PL (+ 268 700 ± 63 983 vs PL: + 8893 ± 6786 pg/mL, P = .009). After treatment, body weight and fasting glucose were not statistically different between PL and BPA-50 (P > .05). However, BPA significantly decreased peripheral insulin sensitivity by 0.02 ± 0.01 mg/kg/min/uU/mL compared with an increase observed following PL by 0.02 ± 0.01 mg/kg/min/uU/mL (P = .01). CONCLUSION: BPA administration decreased peripheral insulin sensitivity after 5 days. These data provide the first experimental evidence in humans that BPA administration may reduce insulin sensitivity.
引用
- Seal AD, Phelan S, Malin SK, et al. Bisphenol A decreases peripheral insulin sensitivity in normal weight adults: a double-blind randomized controlled trial. J Clin Endocrinol Metab. 2026. PMID: 41866316. doi:10.1210/clinem/dgag124
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。